Human and Animal Healthcare
MiCRA is a long‑established innovation hub in human and veterinary diagnostics, with expertise in this field dating back to before the establishment of the Technology Gateway. Our team develops cutting‑edge biosensors, rapid assays, and analytical methodologies that support early detection, improved disease management, and next‑generation diagnostic technologies for both human and animal health.
From farm‑level monitoring to point‑of‑care clinical diagnostics, MiCRA delivers solutions that reduce testing time, increase accuracy, and broaden access to fast, reliable health insights.
Innovative Biosensor & Diagnostic Development
MiCRA has successfully developed prototype biosensors and diagnostic tools for a wide range of human, bovine, and equine health challenges, including:
- Parasitic diseases: liver fluke, stomach worm (nematodes)
- Fertility testing: human and bovine biomarkers
- Inflammation biomarkers: rapid detection to support early intervention
- Allergy testing: including peanut and gluten protein sensitivity
- Metabolic deficiencies: such as phenylketonuria (PKU)
- Enzyme activity profiling: for clinical and veterinary diagnostics
- Infectious diseases: including HSV detection
These innovations are supported by MiCRA’s deep expertise in electrochemical, optical, and immunoassay‑based diagnostic platforms, enabling rapid, sensitive, and cost‑effective detection systems.
Advanced Immunoassay Platforms
MiCRA specialises in next‑generation immunoassays, including:
- Electronic ELISA systems for out‑of‑laboratory or field‑based testing
- Antibody‑ and antigen‑based detection formats
- Microbial cell capture assays
- Sandwich, competitive, and multiplex formats
These formats are ideal for developing rapid diagnostic prototypes for use in clinics, veterinary practices, laboratories, and on‑farm settings.
Our Diagnostic Technology Toolkit
MiCRA’s diagnostics research is powered by a suite of advanced analytical instruments, enabling rapid prototyping, verification, and performance characterisation of diagnostic materials and sensor technologies.
BioDot Automated Diagnostic Unit
Used for rapid development of lateral‑flow and strip‑based diagnostic tests, enabling fast prototyping and optimisation of assays for human and animal health applications.
Autolab Multichannel Potentiostat
Core tool for the development and evaluation of electrochemical biosensors, including enzymatic, immunosensor, and redox‑active clinical markers.
Synergy H1 Multiplate Reader
Supports ELISA development, kinetic assays, biomarker screening, enzyme activity studies, and allergen detection workflows.
CytoFlex S Flow Cytometer
Enables rapid cell‑based diagnostics, microbial detection, immunophenotyping, and evaluation of inflammation or infection‑related biomarkers.
SEM Phenom XL
Used for high‑resolution surface analysis of diagnostic materials, sensor coatings, nanoparticles, and assay substrates—critical for understanding performance at the micro‑ and nanoscale.
Spectroscopy Platforms (FTIR, Raman, NIR)
Bruker Alpha II, MultiRAM, and MPA II systems enable chemical fingerprinting, antigen/ligand identification, and verification of diagnostic materials.
Why Industry Chooses MiCRA for Health Diagnostics
- Proven track record in both human and veterinary diagnostic innovation
- End‑to‑end capability from biomarker exploration to prototype device development
- Rapid prototyping for biosensors, immunoassays, and point‑of‑care devices
- Advanced analytical infrastructure for validation and optimisation
- Collaborative R&D model that accelerates development while protecting IP
MiCRA partners with clinicians, veterinarians, med‑tech innovators, and diagnostic companies to bring new testing solutions to market—faster, more reliably, and with scientifically robust data behind every decision.